psb cb5 tocris Search Results


psb cb5  (Tocris)
93
Tocris psb cb5
Figure 2. Identifying potential receptors through which THC blocks macrophage differentiation. (A–H) Representative flow and graphical representation of macrophage populations at 120 h between VEH- and THC-treated groups. Y-axis on flow plot is CD11b; X-axis is F4/80. (A–D) Preliminary flow gating shown in Figure S1A. (E–H) Preliminary flow gating shown in Figure S1B. (A) Wild-type mice; (B) CB1 knockout mice; (C) CB2 knockout mice; (D) CB1 and CB2 knockout mice; (E) GPR18 antagonist <t>PSB</t> <t>CB5;</t> (F) GPR55 antagonist ML 193; (G) A2aR antagonist SCH 442416; (H) G-PCR inhibitor PTX; (I) List of receptor inhibition methods and related citation. (A–H) n = 3, unpaired t-test was performed, levels of statistical significance were assigned according to the following cutoffs: *** p < 0.001, and **** p < 0.0001.
Psb Cb5, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/psb+cb5+tocris/PSB+CB5/pm39199132-50-13-21
Average 93 stars, based on 1 article reviews
psb cb5 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Figure 2. Identifying potential receptors through which THC blocks macrophage differentiation. (A–H) Representative flow and graphical representation of macrophage populations at 120 h between VEH- and THC-treated groups. Y-axis on flow plot is CD11b; X-axis is F4/80. (A–D) Preliminary flow gating shown in Figure S1A. (E–H) Preliminary flow gating shown in Figure S1B. (A) Wild-type mice; (B) CB1 knockout mice; (C) CB2 knockout mice; (D) CB1 and CB2 knockout mice; (E) GPR18 antagonist PSB CB5; (F) GPR55 antagonist ML 193; (G) A2aR antagonist SCH 442416; (H) G-PCR inhibitor PTX; (I) List of receptor inhibition methods and related citation. (A–H) n = 3, unpaired t-test was performed, levels of statistical significance were assigned according to the following cutoffs: *** p < 0.001, and **** p < 0.0001.

Journal: Antioxidants (Basel, Switzerland)

Article Title: Delta-9-Tetrahydrocannabinol Blocks Bone Marrow-Derived Macrophage Differentiation through Elimination of Reactive Oxygen Species.

doi: 10.3390/antiox13080887

Figure Lengend Snippet: Figure 2. Identifying potential receptors through which THC blocks macrophage differentiation. (A–H) Representative flow and graphical representation of macrophage populations at 120 h between VEH- and THC-treated groups. Y-axis on flow plot is CD11b; X-axis is F4/80. (A–D) Preliminary flow gating shown in Figure S1A. (E–H) Preliminary flow gating shown in Figure S1B. (A) Wild-type mice; (B) CB1 knockout mice; (C) CB2 knockout mice; (D) CB1 and CB2 knockout mice; (E) GPR18 antagonist PSB CB5; (F) GPR55 antagonist ML 193; (G) A2aR antagonist SCH 442416; (H) G-PCR inhibitor PTX; (I) List of receptor inhibition methods and related citation. (A–H) n = 3, unpaired t-test was performed, levels of statistical significance were assigned according to the following cutoffs: *** p < 0.001, and **** p < 0.0001.

Article Snippet: THC was obtained from Cayman Chemical (Ann Arbor, MI, USA); GPCR inhibitors ML193, PSB CB5, SET 2, SCH442416, and Deferoxamine from Tocris (Minneaoikus, MN, USA); Pertussis Toxin (PTX) from List Biological Laboratories (Campbell, CA, USA); Recombinant Murine M-CSF and Annexin V Apoptosis Detection Kit from Biolegend (San Diego, CA, USA); PhenGreen SK (PGSK) and CellROX Deep Red and Sytox Blue from Thermo Fisher (Waltham, MA, USA); Penicillin/Streptomycin, FBS, phosphate-buffered saline (PBS) from VWR (West Chester, PA, USA).

Techniques: Knock-Out, Inhibition